SEPN
Septerna, Inc. Common Stock
NASDAQ: SEPN · HEALTHCARE · BIOTECHNOLOGY
$23.76
+1.32% today
Updated 2026-04-30
Market cap
$1.05B
P/E ratio
—
P/S ratio
22.92x
EPS (TTM)
$-1.10
Dividend yield
—
52W range
$6 – $33
Volume
0.3M
Septerna, Inc. Common Stock (SEPN) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Operating cash flow | $-23.30M | $-38.72M | $-67.47M | $110.19M |
| Capital expenditures | $1.29M | $2.88M | $2.10M | $518000.00 |
| Depreciation | $577000.00 | $848000.00 | $1.40M | — |
| Stock-based comp | $1.52M | $1.62M | $3.15M | $8.48M |
| Free cash flow | $-24.59M | $-41.60M | $-69.57M | $109.67M |
| Investing cash flow | $-1.29M | $22.12M | $-160.60M | — |
| Financing cash flow | $30.05M | $74.52M | $377.78M | — |
| Dividends paid | — | — | — | — |
| Share repurchases | — | — | — | — |
| Debt repayment | — | — | — | — |
| Net change in cash | — | — | — | — |